coronavirus
The coronavirus is currently changing slowly. There are only about two dozen mutations. There have been many reports of multiple strains of SARS-CoV-2. Virologists use the world strain as a label to the same group of samples. This does not …
Antibody levels found in recovered COVID-19 patients fell sharply in 2-3 months after infection for both symptomatic and asymptomatic patients, according to a Chinese study published in Nature Medicine. This raises questions about the length of any immunity against the …
Dexamethasone, a cheap steroid, reduced deaths by one-third in ventilated patients and by one fifth in other patients receiving oxygen only. There was no benefit among those patients who did not require respiratory support. A total of 2104 patients were …
A personal, handheld device emitting high-intensity ultraviolet light to disinfect areas by killing the novel coronavirus is now feasible, according to researchers at Penn State, the University of Minnesota and two Japanese universities. Finding a new material with the right …
Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner expects that any coronavirus vaccine that proves to be safe and effective will still probably only provide immunity for a limited amount of …
Scientists from the University of Maryland School of Medicine (UMSOM) developed an experimental diagnostic test for COVID-19 that can visually detect the presence of the virus in 10 minutes. It uses a simple assay containing plasmonic gold nanoparticles to detect …
Internally applied ultraviolet light could help treat coronovirus patients. The Healight is a catheter embedded with small LED lights that emit UVA. The Healight technology delivers intermittent ultraviolet (UV) A light through an endotracheal catheter and according to the company, …
Moderna (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced positive interim clinical data of mRNA-1273, its vaccine candidate against novel coronavirus (SARS-CoV-2), …
The Coalition for Epidemic Preparedness Innovations, which is funding nine different coronavirus vaccine projects, has previously suggested a shot could be ready within 12 to 18 months, an already ambitious target. That assessment didnt account for the possibility of companies …
Wearing face masks in the community is now generally accepted as highly effective in reducing disease spread. Interventions that bring moderate benefits to individuals can have large population benefits. Seatbelt wearing is one such example. The use of masks and …